bronchicine - zoetis cae is a nonadjuvanted antigenic extract prepared from the cells of bordetella...

1
13845700 Bronchicine CAe is a nonadjuvanted antigenic extract prepared from the cells of Bordetella bronchiseptica recommended for use as an aid in the control of canine infectious tracheobronchitis (kennel cough) caused by the organism represented. The effect of persisting B. bronchiseptica maternal antibody on the immune response in puppies to this bacterin has not been determined. Puppies from bitches immune to the organism usually have low antibody titers that are dissipated by 4-6 weeks of age. Although kennel cough is considered a disease of complex etiology, it can be reproduced by challenge with B. bronchiseptica alone. A close association and/or confinement of dogs facilitates spread of the disease syndrome. Antibiotic therapy has been shown to be generally unsuccessful in reducing or eliminating B. bronchiseptica infection in dogs. Directions: Shake well. Aseptically administer 1 mL subcutane- ously to healthy dogs at least 8 weeks of age. For initial vaccina- tion, a second dose is required 2-4 weeks later. This product should be administered by subcutaneous injection only. Annual revaccination with a single 1 mL dose is recommended. Precautions: Store at 2°-7°C. Do not freeze. Use entire contents when first opened. Care should be taken to avoid microbial contamination of the product. In case of anaphylactoid reactions, epinephrine should be administered immediately. Transient local irritation at the site of injection, though rare, may occur subsequent to use of this product. Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471 (USA), (800) 461-0917 (Canada). ® Bronchicine

Upload: others

Post on 13-Apr-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Bronchicine - Zoetis CAe is a nonadjuvanted antigenic extract prepared from the cells of Bordetella bronchiseptica recommended for use as an aid in the control of canine infectious

Time/Date:

CHANGES

OK

CHANGES

OK

CHANGES

OK

EDITOR’S COPYGS:

DATE:

Additional Info:Colors:

Mgr

GS

GA

J. Ru

stadC

. Teach

ou

tL. N

elson

RevG

A

PR G

S / ART REV (LCA

)G

S / ART REV (FA

)

3

11335

13845700 B

ronchicine U

SA

Visual Code Bars: 1, 5

P

roject N

o.

Artw

ork N

um

ber

Descrip

tion

C

ou

ntry

7 5/32 ” x 3 15/32 ” x 1”

3904A

3551ZTS

Insert Card

Dim

ensio

ns

Draw

ing

No

S

KU

No

. Item

BlackPM

S 308PM

S 306PM

SOrange 021

PMS 109

Dieline

BordetellaBronchisepticaBacterinCellular Antigen Extract

For use in dogs only

50 1-dose (1-mL) vials of bacterin

13845700

13845700

Administer tw

o 1-mL doses subcutaneously 2−

4 weeks apart to dogs

8 weeks of age or older. Store at 2°−

7°C. Do not freeze. See back of card for com

plete directions.

U.S.

Vet

erin

ary

Lice

nse

No. 1

90Zo

etis

Inc.

Kala

maz

oo, M

I 490

07, U

SA

Bronchicine CAe is a nonadjuvanted antigenic extract prepared from the cells of Bordetella bronchiseptica recommended for use as an aid in the control of canine infectious tracheobronchitis (kennel cough) caused by the organism represented.

The effect of persisting B. bronchiseptica maternal antibody on the immune response in puppies to this bacterin has not been determined. Puppies from bitches immune to the organism usually have low antibody titers that are dissipated by 4−6 weeks of age. Although kennel cough is considered a disease of complex etiology, it can be reproduced by challenge with B. bronchiseptica alone.A close association and/or con�nement of dogs facilitates spread of the disease syndrome. Antibiotic therapy has been shown to be generally unsuccessful in reducing or eliminating B. bronchiseptica infection in dogs.

Directions: Shake well. Aseptically administer 1 mL subcutane-ously to healthy dogs at least 8 weeks of age. For initial vaccina-tion, a second dose is required 2−4 weeks later. This product should be administered by subcutaneous injection only. Annual revaccination with a single 1 mL dose is recommended.

Precautions: Store at 2°−7°C. Do not freeze. Use entire contents when �rst opened. Care should be taken to avoid microbial contamination of the product. In case of anaphylactoid reactions, epinephrine should be administered immediately. Transient local irritation at the site of injection, though rare, may occur subsequent to use of this product.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471 (USA), (800) 461-0917 (Canada).

®Bronchicine

F.P.O. UPC

®

Bronchicine®

Bronchicine

®

Bron

chic

ine

®Bronchicine

®Bronchicine

13845700.pdf 1 9/11/13 1:02 PM